在低资源环境下,怀孕期间治疗宫癌:一个罕见的病例报告
Namkha Dorji1,2, Rojna Rai3, Nishal Chhetri4
1Department of Obstetrics and Gynecology, Jigme Dorji Wangchuck National Referral Hospital National Referral Hospital, Thimphu, Bhutan. namji2002@gmail.com.
BMC pregnancy and childbirth
|September 12, 2024
概括
怀孕期间的宫癌是罕见的,难以管理的,特别是在资源较低的地区. 本案例报告详细介绍了不丹一名孕妇FIGO阶段IB3宫癌的成功管理.
科学领域:
- 产科和妇科 产科和妇科
- 在瘤学瘤学.
背景情况:
- 宫癌复杂化怀孕带来了罕见的诊断和管理挑战.
- 缺乏资源的环境加剧了怀孕期间治疗宫癌的困难.
研究的目的:
- 报告在低资源国家管理的怀孕期间发生的宫癌病例.
- 突出在资源有限的环境中怀孕期间诊断和治疗宫癌的复杂性.
主要方法:
- 一例FIGO阶段IB3宫癌的病例是在怀孕28周和5天时被诊断出来的.
- 患者是一名27岁的女性,她的病情得到了成功的治疗.
主要成果:
- 在孕妇患者的FIGO阶段IB3宫癌的成功管理.
- 在怀孕37周和2天后,分娩发生.
结论:
- 这是不丹首次报告怀孕期间出现宫癌的病例.
- 这一案例强调了在低资源环境中,对于患有子宫癌的孕妇患者来说,存在重大诊断和管理障碍.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


